Extracellular “calcistat” in health and disease
- 1 January 1999
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 353 (9147) , 83-84
- https://doi.org/10.1016/s0140-6736(05)76148-1
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells.Journal of Clinical Investigation, 1996
- Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidismHuman Molecular Genetics, 1996
- Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains.Journal of Clinical Endocrinology & Metabolism, 1996
- Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism.Journal of Clinical Investigation, 1995
- Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidismCell, 1993
- Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroidNature, 1993
- Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengersPhysiological Reviews, 1991
- Familial Benign Hypercalcemia (Hypocalciuric Hypercalcemia)Annals of Internal Medicine, 1985
- An Association between Neonatal Severe Primary Hyperparathyroidism and Familial Hypocalciuric Hypercalcemia in Three KindredsNew England Journal of Medicine, 1982
- The Hypocalciuric or Benign Variant of Familial Hypercalcemia: Clinical and Biochemical Features in Fifteen KindredsMedicine, 1981